FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds of formula (I) possessing BACE1 inhibitor property. In general formula (I), X denotes hydrogen or fluorine; A denotes CH or N; Y denotes methyl, ethyl, monofluoromethyl, difluoromethyl, trifluoromethyl, difluoroethyl, methoxy, ethoxy, methoxymethyl or - C≡N.
EFFECT: treatment of diseases mediated by activity of BACE1, including neurodegenerative diseases, such as Alzheimer type dementia or Down syndrome.
12 cl, 5 tbl, 1 dwg, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDENSED AMINOHYDROTHIAZINE DERIVATIVE | 2009 |
|
RU2476431C2 |
| PHARMACEUTICAL COMPOSITION BASED ON CONDENSED DERIVATIVE OF AMINODIHYDROTHIAZINE | 2015 |
|
RU2710227C2 |
| AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
| COMPOSITION CONTAINING ANTIBODY AGAINST ABETA PROTOFIBRILS AND INHIBITOR OF BETA-SECRETASE BACE1 FOR TREATMENT OF ALZHEIMER'S DISEASE | 2017 |
|
RU2786476C2 |
| MACROCYCLIZATION REACTIONS AND INTERMEDIATE COMPOUNDS AND OTHER FRAGMENTS SUITABLE FOR PREPARING ANALOGUES OF HALICHONDRIN B | 2014 |
|
RU2710545C2 |
| SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
| PHENYLOXAZOLIDINONES HAVING C-C-BOND WITH 4-8-MEMBERED HETEROCYCLIC RINGS | 1996 |
|
RU2175324C2 |
| N-[3-(5-AMINO-3,3A,7,7A-TETRAHYDRO-1H-2,4-DIOXA-6-AZA-INDEN-7-YL)-PHENYL]-AMIDES AS INHIBITORS OF BACE1 AND(OR) BACE2 | 2012 |
|
RU2597308C2 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019 |
|
RU2822216C2 |
